114 related articles for article (PubMed ID: 36513743)
1. Phosphohistidine signaling promotes FAK-RB1 interaction and growth factor-independent proliferation of esophageal squamous cell carcinoma.
Zhang J; Gelman IH; Qu J; Hochwald SN
Oncogene; 2023 Feb; 42(6):449-460. PubMed ID: 36513743
[TBL] [Abstract][Full Text] [Related]
2. Glucose Drives Growth Factor-Independent Esophageal Cancer Proliferation via Phosphohistidine-Focal Adhesion Kinase Signaling.
Zhang J; Gelman IH; Katsuta E; Liang Y; Wang X; Li J; Qu J; Yan L; Takabe K; Hochwald SN
Cell Mol Gastroenterol Hepatol; 2019; 8(1):37-60. PubMed ID: 30836148
[TBL] [Abstract][Full Text] [Related]
3. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma.
Shin WS; Kwon J; Lee HW; Kang MC; Na HW; Lee ST; Park JH
Cancer Sci; 2013 Aug; 104(8):1120-6. PubMed ID: 23663482
[TBL] [Abstract][Full Text] [Related]
5. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
Zhu ZQ; Hu HF; Zheng XY; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
[No Abstract] [Full Text] [Related]
6. The diacylglycerol kinase α (DGKα)/Akt/NF-κB feedforward loop promotes esophageal squamous cell carcinoma (ESCC) progression via FAK-dependent and FAK-independent manner.
Chen J; Zhang W; Wang Y; Zhao D; Wu M; Fan J; Li J; Gong Y; Dan N; Yang D; Liu R; Zhan Q
Oncogene; 2019 Apr; 38(14):2533-2550. PubMed ID: 30532074
[TBL] [Abstract][Full Text] [Related]
7. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.
Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H
Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC).
Chen J; Zhao D; Zhang L; Zhang J; Xiao Y; Wu Q; Wang Y; Zhan Q
Cell Mol Immunol; 2022 Sep; 19(9):1054-1066. PubMed ID: 35962191
[TBL] [Abstract][Full Text] [Related]
9. Membrane Metalloendopeptidase (MME) Suppresses Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) by Inhibiting FAK-RhoA Signaling Axis.
Li M; Wang L; Zhan Y; Zeng T; Zhang X; Guan XY; Li Y
Am J Pathol; 2019 Jul; 189(7):1462-1472. PubMed ID: 31054987
[TBL] [Abstract][Full Text] [Related]
10. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Zheng L; Zhao Z; Rong L; Xue L; Song Y
J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
12. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.
Twarock S; Tammi MI; Savani RC; Fischer JW
J Biol Chem; 2010 Jul; 285(30):23276-84. PubMed ID: 20463012
[TBL] [Abstract][Full Text] [Related]
13. Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions.
Han BB; Li S; Tong M; Holpuch AS; Spinney R; Wang D; Border MB; Liu Z; Sarode S; Pei P; Schwendeman SP; Mallery SR
Cancer Prev Res (Phila); 2015 May; 8(5):419-30. PubMed ID: 25712051
[TBL] [Abstract][Full Text] [Related]
14. Chrysin serves as a novel inhibitor of DGK
Chen J; Wang Y; Zhao D; Zhang L; Zhang W; Fan J; Li J; Zhan Q
Acta Pharm Sin B; 2021 Jan; 11(1):143-155. PubMed ID: 33532186
[TBL] [Abstract][Full Text] [Related]
15. Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Li J; Chen Y; Zhan C; Zhu J; Weng S; Dong L; Liu T; Shen X
Dig Dis Sci; 2019 Jun; 64(6):1493-1502. PubMed ID: 30730015
[TBL] [Abstract][Full Text] [Related]
16. IGF2BP1/UHRF2 Axis Mediated by miR-98-5p to Promote the Proliferation of and Inhibit the Apoptosis of Esophageal Squamous Cell Carcinoma.
Fang XY; Sun JJ; Chen SY; Wu KJ; Yu Y; Zhang C; Duan CZ
Ann Clin Lab Sci; 2021 May; 51(3):329-338. PubMed ID: 34162562
[TBL] [Abstract][Full Text] [Related]
17. Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma.
Kim JH; Shin WS; Lee SR; Kim S; Choi SY; Lee ST
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293051
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway.
Sun Y; Qian Y; Chen C; Wang H; Zhou X; Zhai W; Qiu L; Zhou X; Ning H; Zhao Y; Shi C; Han L; Qi Y; Wu Y; Gao Y
J Exp Clin Cancer Res; 2022 Apr; 41(1):145. PubMed ID: 35428295
[TBL] [Abstract][Full Text] [Related]
19. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition.
Luo QY; Zhou SN; Pan WT; Sun J; Yang LQ; Zhang L; Qiu MZ; Yang DJ
Biochem Pharmacol; 2021 Jan; 183():114318. PubMed ID: 33159967
[TBL] [Abstract][Full Text] [Related]
20. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
Gen Y; Yasui K; Nishikawa T; Yoshikawa T
Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]